Company intelligence / Profile preview

BioRender

Ownership: Private
Employees: ~61
Development stage: Commercial

Overview

BioRender provides a cloud-based platform enabling researchers in life sciences, biotech, pharma, and academia to create professional-quality scientific figures using an extensive library of pre-made icons and templates. The tool accelerates science communication by making complex concepts visually accessible without requiring graphic design expertise[2][3][5].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Academic institutions (various)Pharmaceutical companies (various)Biotech firms (various)[2]

Beyond the preview

Go deeper on BioRender.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioRender.

Explore the full profile